| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sr VP, Clinical Dev. &CMO | Sr VP Clinical Dev &CMO | Sr VP, Clinical Dev &CMO +1 more
1 company
Wigginton Jon Marc is a Sr VP, Clinical Dev. &CMO at MACROGENICS INC. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $87K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 17, 2018 | MGNX MacRogenics Inc | Sr VP, Clinical Dev. &CMO | Sale+OE | 5,000 | $20.00 | $100,000.00 | -7.7% | |
| Nov 21, 2017 | MGNX MacRogenics Inc | Sr VP, Clinical Dev. &CMO | Sale+OE | 5,000 | $20.00 | $100,000.00 | -14.3% | |
| Oct 25, 2017 | MGNX MacRogenics Inc | Sr VP, Clinical Dev. &CMO | Sale+OE | 10,000 | $20.00 | $200,000.00 | -25.0% | |
| Jun 5, 2017 | MGNX MacRogenics Inc | Sr VP, Clinical Dev. &CMO | Sale+OE | 5,000 | $20.00 | $100,000.00 | -14.3% | |
| Apr 19, 2017 | MGNX MacRogenics Inc | Sr VP, Clinical Dev. &CMO | Sale+OE | 15,000 | $20.00 | $300,000.00 | -33.3% | |
| Oct 3, 2016 | MGNX MacRogenics Inc | Sr VP, Clinical Dev. &CMO | Sale+OE | 10,000 | $29.34 | $293,400.00 | -100% | |
| Aug 1, 2016 | MGNX MacRogenics Inc | Sr VP Clinical Dev &CMO | Sale+OE | 20,000 | $30.78 | $615,600.00 | -100% | |
| Jul 1, 2016 | MGNX MacRogenics Inc | Sr VP Clinical Dev &CMO | Sale+OE | 5,000 | $27.22 | $136,100.00 | -100% | |
| Jan 4, 2016 | MGNX MacRogenics Inc | Sr VP, Clinical | Sale+OE | 10,000 | $29.64 | $296,400.00 | -100% | |
| Oct 1, 2015 | MGNX MacRogenics Inc | Sr VP, Clinical | Sale+OE | 5,000 | $21.11 | $105,550.00 | -100% |